We demonstrate a multi-spectral scanning fiber endoscope (SFE) that collects fluorescence images in vivo from three target peptides that bind specifically to murine colonic adenomas. This ultrathin endoscope was demonstrated in a genetically engineered mouse model of spontaneous colorectal adenomas based on somatic Apc (adenomatous polyposis coli) gene inactivation. The SFE delivers excitation at 440, 532, 635 nm with <2 mW per channel. The target 7-mer peptides were conjugated to visible organic dyes, including 7-Diethylaminocoumarin-3-carboxylic acid (DEAC) (λ ex =432 nm, λ em =472 nm), 5-Carboxytetramethylrhodamine (5-TAMRA) (λ ex =535 nm, λ em =568 nm), and CF-633 (λ ex =633 nm, λ em =650 nm). Target peptides were first validated using techniques of pfu counting, flow cytometry and previously established methods of fluorescence endoscopy. Peptides were applied individually or in combination and detected with fluorescence imaging. The ability to image multiple channels of fluorescence concurrently was successful for all three channels in vitro, while two channels were resolved simultaneously in vivo. Selective binding of the peptide was evident to adenomas and not to adjacent normal-appearing mucosa. Multispectral wide-field fluorescence detection using the SFE is achievable, and this technology has potential to advance early cancer detection and image-guided therapy in human patients by simultaneously visualizing multiple over expressed molecular targets unique to dysplasia.
INTRODUCTION
Colorectal cancer is the 3 rd most common and the 2 nd leading cause of cancer-related deaths in the U.S. 1 Despite the increased availability of colonoscopy screening, mortality and morbidity rates associated with this disease remain high. Specifically, miss rates for flat or depressed colonic lesions have been reported as greater than 20%. 2 This occurs because these lesions are difficult to visualize with traditional methods of white light endoscopy. 3, 4 White light endoscopy is limited to the viewing of reflected visible light from the surface of the mucosal wall and requires multiple biopsies with pathohistological analysis for diagnosis. A targeted method of detection using recent advances in fiber optics, light sources, detectors, and molecular biology can improve our ability to image the colonic epithelium in real-time, avoiding sampling error, processing delays, and bleeding risk. 5 Changes in molecular expression within transformed cells occur well in advance of any detectable anatomical feature change. Detecting these neoplastic transformations at the cellular level over a wide area is an opportunity for early detection of cancer in the digestive tract. In particular, colorectal cancer can present with multiple upregulated cell surface targets (e.g. epidermal growth-factor receptor, epithelial cell adhesion molecule, mucin 1, etc.) that can theoretically be visualized with fluorescence-labeled targeted peptides during routine screening to guide tissue biopsy, assess for sub-mucosal invasion, and monitor response to therapy. 6 Fluorescent imaging probes already developed include proteolytic enzymes, matrix metalloproteinases, endothelial-specific markers, and apoptosis reporters; [7] [8] [9] [10] however, limitations such as delivery challenges, immunogenicity, and cost for these probes exist. Peptides are small in size, have minimal immunogenicity, possess rapid binding kinetics, and are easily conjugated to multiple fluorescence labels, making them attractive molecules for clinical use. We have previously demonstrated that peptides derived from phage display technologies can preferentially bind to diseased tissue in the esophagus and colon. 5, 11, 12 Current wide-area methods that are being developed to aid traditional colonoscopy in the identification of neoplastic tissue from variations in tissue micro-architecture include narrow band imaging (NBI), Chromoendoscopy, and autofluorescence imaging. NBI relies on enhanced contrast from capillaries or veins by using appropriate filters that enhance hemoglobin absorption, allowing diseased tissue to appear darker in color than normal surrounding tissue. 13 Clinical studies have reported that narrow-band imaging alone may not aid in dysplastic tissue detection, still requiring white light endoscopy for guided tissue biopsy. Chromoendoscopy utilizes a non-specific exogenous dye, such as indigo carmine, to enhance micro-anatomical changes in the mucosa.
14 Like NBI, Chromoendoscopy relies on white light endoscopy for guided tissue biopsy and may miss flat lesions that do not present sufficient contrast in topographical changes of the epithelium. Autofluorescence imaging relies on decreased endogenous fluorescence from molecules such as collagen, NADH, FAD, and porphyrins. 15 Debris and mucosal folds that cause shadows can also limit the specificity of this approach. Additional imaging modalities being developed to improve the clinician's ability to access, image, and diagnose disease in the gastrointestinal tract include light scattering spectroscopy, endoscopic optical coherence tomography, and confocal endoscopy. To be effective for improving disease diagnosis, a modality must augment current endoscopic capabilities with the intent of being utilized in tandem with conventional white light endoscopy. The scanning fiber endoscope (SFE) is a ultrathin and flexible (endoscopecompatible) instrument that spirally scans focused red, green, and blue laser beams onto the tissue surface, collecting backscattered light using a ring of multi-mode optical fibers. 16 We have developed a novel method using the SFE for simultaneously detection of multiple fluorescent probes.
The aim of this study is to demonstrate an integrated methodology using the multi-spectral SFE to collect wide-field fluorescence images in vivo from multiple target peptides that bind to murine colon dysplasia. We used phage display technology to identify short peptide sequences that preferentially home to dysplasia. Using methods of in vivo phage panning on a genetically engineered mouse model of spontaneous colorectal dysplasia, based on somatic Apc (adenomatous polyposis coli) gene inactivation, we have identified several peptide candidates that bind to colonic dysplasia in the mouse. Additional in vitro phage display experiments on human colon carcinoma cells have provided more peptide candidates that could prove efficacious in early cancer detection. 17 Here; we employ a new approach for imaging multiple peptides simultaneously to demonstrate the ability of this integrated strategy to perform multiple biomarker detection in vivo.
MATERIALS AND METHODS

Multi-Spectral Scanning Fiber Endoscope
A scanning fiber endoscope system was adapted for fluorescence detection in three channels (RGB) using excitation at 440 (NDHB510APA, Nichia, Tokyo, Japan), 532 (FTEC532-V10TA0, Blue Sky Research, Milpitas, CA) and 635 (FMXL635-017TA0B, Blue Sky Research) nm using an RGB coupler (OZ Optics, Ottawa, Canada). The 3 laser sources are delivered simultaneously into the scanning fiber, and focused to the same point on the illumination plane using a custom lens assembly, as shown in the schematic in Fig. 1A . The laser power coming out of the distal tip of the endoscope is <2mW for each channel, a level consistent with a non-significant risk (NSR) determination by the U.S. Food and Drug Administration (FDA, 21 CFR 812) for future human clinical studies. We reduced the amplitude of the spiral scanner to achieve a divergence angle of 70 deg (max 100 deg) to minimize noise in the periphery of the image. Diffraction-limited imaging can be achieved by reducing the scan angle in real time while capturing the same number of pixels. Fluorescence is collected by a ring of 12 step-index plastic optical fibers (POF) with numerical aperture (N.A.) of 0.63 and outer diameter of 250 µm (Toray Industries Inc, Tokyo, Japan). The detection system, uses long pass (λ LP = 450 nm) and notch (λ N1 = 532 nm and λ N2 = 632.8 nm) filters (Edmund Optics Inc, Barrington, NJ) to reject the reflectance component (RGB laser excitation) of the light emerging from the collection fibers. The fluorescence component is deflected into three individual channels using dichroic beam splitters DM1 (λ c = 440 nm) and DM2 (λ c = 532 nm) (Chroma Technology Corp, Bellows Falls, VT). An additive RGB set of dichroics (λ R,G,B , part# 52-546, Edmund Optics Inc) is used to filter the individual fluorescence beams, which are focused onto separate PMT (H7826-01, Hamamatsu Corp, Hamamatsu City, Japan) detectors using an objective lens (O R,G,B , f = 25 mm, N.A. = 0.46). The PMT signals are sampled at 25 MHz to generate video rate (30 Hz) images.
Mouse Models and In Vivo Phage Panning
Mice were cared for under the approval of the University Committee on the Use and Care of Animals, University of Michigan (UCUCA) (Approved protocol 09881) and housed in specific pathogen-free conditions and supplied water ad libitum throughout the study. A 7-month old CPC;Apc mouse was injected via tail vein with 2x10 11 pfu of the parent M13-7mer Ph.D.7™ Phage Display Library (New England Biolabs, ). The library was allowed to circulate for 10 min, after which the mouse was euthanized by carbon dioxide asphyxiation and immediately heart-perfused with phosphate buffer solution with protease inhibitors (PBS-PI): 1 mM phenylmethanesulfonylfluoride (PMSF), 20 µg/mL aprotinin, and 1 µg/mL leupeptin). Organs were extracted after perfusion and kept on ice. The bound phages were recovered by homogenizing each tissue or organ (Bio-gen Pro 200) in DMEM-PI ((Dulbecco's Modified Eagle Medium plus protease inhibitors: 1 mM phenylmethanesulfonylfluoride (PMSF), 20 µg/mL aprotinin, and 1 µg/mL leupeptin). The tissue samples were washed 3x with ice-cold washing medium (DMEM-PI containing 1% bovine serum albumin (BSA)), centrifuging for 5 min at 3000 rpm between each wash. After the last wash, freshly starved Escherichia coli (ER2738) were added to each tissue homogenate and incubated for 30 min at room temperature (RT). Pre-warmed Luria-Bertani (LB) medium was then added to the bacteria-homogenate solution and incubated for an additional 30 min at RT. The supernatant was recovered after centrifugation and titered to determine the number of bound phage within each tissue tested. This procedure constituted one round of panning. A total of three rounds of phage panning were performed, with amplification of the recovered eluate after each panning round. The input phage number (2x10 11 pfu) was kept constant for each round of panning. Titering was performed with appropriate serial dilutions for both eluted phage and amplified phage after each round of panning. Agar plates treated with IPTG (isopropyl-b-D-thiogalactosidase) and Xgal (5-bromo-4-chloro-3-indoyl-b-D-thiogalactosidase) were able to visually identify plaques using blue/white screening. Amplified phages from selected phage plaques were purified by PEG/NaCl (polyethylene glycol/sodium chloride) precipitation. All M13 DNA was sequenced after isolating single stranded DNA using an iodide buffer extraction via dideoxy chain termination using a DNA sequencer (Applied Biosystems, 3730XL DNA Analyzer, UM DNA Core) with the NEB-96 gIII sequencing primer provided by New England Biolabs (# S1259S). The number of phages bound to each organ or tissue was calculated as the output pfu/(input pfu x tissue mass).
Flow Cytometry Validation
Primary colon epithelial cells were extracted from freshly excised colon adenomas from euthanized CPC; Apc mice. Freshly isolated tissue was minced with sterile razor blades into pieces <1 mm in size and washed with a tissue rinse solution (Hank's balanced salt solution containing 2% glucose, 250 µg/mL Amphotericin B, and 10 µg/mL penicillin-streptomycin). The tissue was centrifuged at 5000 rpm for 3 min and the supernatant was aspirated. The tissue was washed again and then digested in HBSS containing 2% bovine serum albumin, 60 units/mL collagenase, 0.02 mg/mL dispase I, 0.2 mg/mL soybean trypsin inhibitor for 18 hrs at 37°C. Epithelial cells were separated and collected as a pellet after two rinses with wash media (Dulbecco's medium containing 2% sorbitol, 5% fetal bovine serum, and 10 µg/mL penicillin-streptomycin).
FITC-labeled phage were prepared by combining 1 ×10
13 pfu of phage in 200 µL of 1M Sodium Carbonate conjugation buffer (pH 9.0) with 20 µL of 5 mg/mL FITC in the same conjugation buffer and rotating in the dark for 2 hr. Purification and concentration of the phage was accomplished by transferring the solution to Amicon Ultracel 3k centrifugal filters (Millipore UFC800396), adding 3.5 mL of PBS and centrifuging (Eppendorf 5810R) at 4000 rpm and 4ºC for 35min, discarding the wash and repeating for a total of 3 times ending with a total volume of 150 µL of phage solution. The phage solution was tittered to determine end phage concentration.
x 10
7 primary epithelial cells per sample were blocked with PBS containing 1% BSA for 30 min on ice. Cells were centrifuged at 2000 rpm for 5 min and washed twice with PBS containing 1% BSA, centrifuging after each wash. Cells were then incubated with 1 x 10 10 FITC-conjugated phages of each individual clone being tested in PBS for 1 hr on ice with gentle shaking. Cells were subsequently washed in PBS with 1% BSA thrice, centrifuging after each wash. Cells were resuspended in PBS and immediately analyzed on a FACSDiVa flow cytometer (BD ® LSRII, BD Biosciences, San Jose, CA; FlowJo Analysis Software, Tree Star Inc. Ashland, OR). A wild-type phage containing no peptide insert was labeled with FITC and used as a control. Forty-two independent phage clones were tested in duplicate. Target to background ratios against the wild-type FITC-phage clone were calculated as: Mean FITC value of candidate phage/Mean FITC value of wild-type phage. The top six phages having the highest target/background values were further synthesized as peptides for preliminary testing in vivo.
Peptide synthesis
The peptides were synthesized using standard Fmoc-chemistry by solid phase synthesis. To ensure the phage and synthetic peptide were expressed with the same orientation, the candidate peptide was synthesized with 5'-fluorescein isothiocyanate (FITC) attached to the carboxy-terminus of the peptide via GGGS linker. Additional lysine residue was appended at the C-terminus to conjugate with fluorophore dyes. The control peptides were also prepared using the same method. The candidate peptides for the validation study were labeled with 5'-FITC (Anaspec, Fremont, CA) at the C-terminus on the side chain of a lysine residue via a GGGSK linker. The candidate peptides for the multi-spectral study were labeled with three different organic fluorophores.
7-Diethylaminocoumarin-3-carboxylic acid (DEAC, Sigma-Aldrich, St. Louis, MO) has a peak absorption and emission at 432 and 472 nm, respectively. 5-Carboxytetramethylrhodamine (5-TAMRA, Chempep, Wellington, FL) has peak absorption and emission at 541 and 568 nm, respectively. CF633 (Biotium Inc., Hayward, CA) has a peak absorption and emission at 630 and 650 nm, respectively. These dyes have peak absorption that approximately matches the laser sources in SFE system. In addition, the peptide GGGAGGGAGGGK was used as a control. Deprotection and cleavage of the peptides were achieved by treatment with a cleavage cocktail of trifluoroacetic acid (TFA)/Tri-isopropylsilane/water (9.5/0.25/0.25, v/v/v) at RT for 3-4 hours. After cleavage of the product from the resin, the peptides were purified by preparative-HPLC using a water (0.1% TFA)-acetonitrile (0.1%TFA) gradient (2-33% acetonitrile over 31 min) (Waters Breeze HPLC, Milford, MA). The peptides were characterized by an ESI mass spectrometer (Micromass LCT Time-of-Flight mass spectrometer with Electrospray. The purity (>95%) of the compound was confirmed by analytical HPLC on a C18 column. All peptides were reconstituted in 1x phosphate buffered saline (PBS) at 500 μM and further diluted in 1x PBS as necessary.
Prior to peptide administration, the colon was prepped using a tap water lavage. Using a small animal endoscope (Karl Storz Veterinary Endoscopy, Goleta, CA) with a 3Fr instrument channel for performing biopsy, adenomas suitable for peptide administration were located, and the colon was rinsed with water until all mucous and debris were removed. The fluorescence-labeled peptide was delivered at a concentration of 100 µM in 1x PBS through the instrument channel of the Storz endoscope. The peptide was allowed to incubate for 5 min after which the colon was cleansed 3x with a tap water to remove the unbound peptide. Prior to imaging, the colon was inspected for residual peptide solution, and when clean, the colon was insufflated with air and imaged with SFE system. Cre-recombinase negative littermates that do not express colonic adenomas were used as controls and imaged with all peptide to know the specificity. Videos collected during endoscopy were exported as avi video files and converted into sequential png images using Apple QuickTime. White light and fluorescence images for each adenoma were analyzed in NIH Image J. The white light image was utilized to draw a region of interest (ROI) around the adenoma or adjacent normal appearing colonic mucosa which was then superimposed onto the fluorescence image. The mean fluorescence intensities were calculated for each ROI, and a target/background (T/B) ratio was calculated for each colonic adenoma and compared to the surrounding normal appearing mucosa. Target to background ratios were not calculated for Cre recombinase negative littermate control mice, because these mice were devoid of adenomas.
Statistics
All results are shown as mean ± mean standard deviation. A non-parametric Mann-Whitney Independent Samples test was performed to determine statistical significance which was defined as p<0.05 between target and control peptide binding to colonic adenomas (SPSS 15.0.; SPSS, Chicago, IL).
Histology
All tissue was fixed in 10% buffered formalin for 24 hours, paraffin-embedded and sectioned into 10 μm thin slices and stained with hematoxylin and eosin (H&E). Histological images were captured using an Axioskop2 upright microscope (Carl Zeiss Microimaging, Inc. Thornwood, NY).
RESULTS
Multi-Spectral Scanning Fiber Endoscope
The en face (top) and side-view (bottom) of distal tip of the flexible multi-spectral endoscope (1.6 mm outer diameter) is shown in Fig. 1A . The distal end of the single illumination optical fiber is scanned in 250 circles in a growing spiral pattern at approximately 11.5 kHz. This scanning strategy can be appreciated by the faint spiral of periodic noise from laser reflectance off the cover glass in Fig. 2B and 2C . The sub-millimeter lens assembly seals the distal tip of the instrument and extends the waist of the laser beam to define a depth of focus that ranges between 2 to 50 mm. We achieved a spatial resolution of <15 µm at a distance of 3 mm from the distal tip to the illumination plane and <1 mm at the maximum depth of focus. This unique combination of scanning mechanism and optics allows for a flexible instrument to be realized in a much smaller package yet match the high-quality images from standard medical endoscopes. Figure 1B shows the emission spectral profile of the dyes which are compatible with the laser source of the system. Images of the droplets of KCCFPAQ-DEAC, AKPGYLS-TAMRA, LTTHYKL-CF633, (100µM each peptide) on a cover glass are shown in Fig. 1C which demonstrates the capability of the multispectral scanning fiber endoscope to simultaneously detect multiple peptides conjugated to various fluorophores over the visible spectrum.
Small Animal Endoscopy and Peptide Administration
Peptide Selection and Validation
After 3 rounds of in vivo phage biopanning that included heart perfusion as a method for clearing non-specific vascular binders, the preference of the phage pools collected during all rounds of panning indicated that the phages were binding more specifically to colonic adenomas in comparison to normal appearing adjacent colonic mucosa, kidney and liver ( Fig. 2A) . Phages that bound to colonic adenomas approximately 10 times greater in number than to normal appearing colonic mucosa were chosen. As a result, 42 individual phage clones were sequenced from the third round of biopanning, and were individually amplified and conjugated to 5'-FITC. Binding to isolated colonic epithelial cells from adenomas for each phage clone was analyzed using flow cytometry (Fig. 2B) . A common 7-mer phage that expresses the sequence HAIYPRH is a known contaminant, and was run (labeled # in Fig. 2B ) to ensure the validity of the assay. 18 The T/B ratio for clone HAIYPRH was found to be 1.10±0.08, indicating minimal binding from a non-specific clone, as expected. Six phage clones with a T/B ratio (target to wild-type phage) >1.9 were identified as ALTPTPP, NLVNLLP, ANYPREP, ATTVPAS, LTTHYKL, and AKPGYLS (labeled * in Fig.  2B ). In addition, the KCCFPAQ peptide was previously found to bind to human HT29 cells. 17 These 7 peptides were synthesized and conjugated to 5'-FITC for evaluation of in vivo binding. In addition, peptide GGGAGGG was used as a control. In vivo imaging of the FITC-labeled peptides with the non-scanning endoscope demonstrated that KCCFPAQ, AKPGYLS, and LTTHYKL exhibited the highest T/B ratio 1.69 ± 0.70; 1.53 ± 0.48 and 1.50 ± 0.73 respectively for binding to colonic adenomas in vivo. These 3 peptides were subsequently conjugated to 7-Diethylaminocoumarin-3-carboxylic acid (DEAC), 5-Carboxytetramethylrhodamine (TAMRA), and CF633, respectively, for in vivo imaging with the multi-spectral scanning fiber endoscope. The control peptides GGGAGGGAGGGK (DEAC)-NH 2 and GGGAGGGAGGGK (5-TAMRA)-NH 2 were also synthesized.
In Vivo Imaging with Multi-spectral fluorophore labeled peptides using SFE
Images collected with the fluorescent-labeled peptides A) KCCFPAQ-DEAC, B) AKPGYLS-TAMRA, and C) LTTHYKL-CF633 administrated individually are shown in Fig. 3 . Specific binding of each peptide to colonic dysplasia (arrows) is demonstrated by comparing the fluorescence images with the corresponding white light images collected with the non-scanning endoscope shown in the panels directly below, Fig. 3D-F) . The lesion margins on fluorescence appear to be sharp in comparison to that on the white light images. The fluorescent-labeled peptides KCCFPAQ-DEAC and AKPGYLS-TAMRA clearly displayed specific binding to colonic dysplasia while that for the LTTHYKL-CF633 peptide appears to be more subtle. The average T/B ratios of peptide binding to dysplasia versus normal appearing adjacent colonic mucosa were 1.71 ± 0.19 (range 1.50 -2.06) and 1.67 ± 0.12 (1.50 -1.78) for KCCFPAQ-DEAC and AKPGYLS-TAMRA, respectively, while that for LTTHYKL-CF633 was not measured because of low signal level. Representative histology (H&E) of the adenoma and adjacent normal appearing mucosa is shown in Fig. 3G and 3H, respectively, scale bar 100 µm. The dysplastic crypts show features, such as enlarged nuclei, disorganization, hyperchromaticity, crowded lamina propria, and distorted architecture, similar to that seen in human sporadic adenomas.
Administration of the candidate peptides to normal colonic mucosa resulted in minimal signal, a result comparable to that found with no administration of peptide (autofluorescence) (data not shown). Also, minimal signal is seen for binding of the control peptides GGGAGGG-DEAC and GGGAGGG-TAMRA to the adenomas (arrows), resulting in T/B ratios of 1.19±0.09 and 1.32±0.10, respectively. Statistical differences between the target and control peptides for KCCFPAQ and AKPGYLS were p = 0.009 and p = 0.001, respectively. A quantitative comparison of fluorescence intensities for binding of the control peptide to adenomas and autofluorescence (no peptide) could not be made because the effect on the low signal levels by the system autogain function.
Combined Targeted In Vivo Images
White light images of colonic adenomas from 3 different mice are shown along the first column in Fig. 4 . Subsequent administration of the KCCFPAQ-DEAC and AKPGYLS-TAMRA peptide results in separate spatial patterns of binding to colonic dysplasia in the blue and green channels, as shown by the overlay image in Fig. 4A . This result suggests that each peptide binds to a different cell surface target. Combined administration of the control peptides GGGAGGG-DEAC and GGGAGGG-TAMRA resulted in similar intensity to that found for autofluorescence where no peptide was administered (data not shown).
DISCUSSION
The reported work demonstrates the ability of the SFE to image multiple fluorescence-labeled peptides independently and simultaneously in vivo over a large mucosal surface area in real time. This advance can be used to localize the presence of dysplasia for early cancer detection as well as to improve the precision of tumor margin detection for endoscopic mucosal resection. While 2 channels were demonstrated in this study, this approach can be extended to 3 or more channels in a straightforward manner within the visible spectrum and more channels if nearinfrared illumination/detection is added to the SFE. Multi-spectral images can be collected to distinguish the contribution of individual over-expressed gene targets by examining unique spatial expression patterns, a technique that is promising for studying epigenetic and environmental factors that influence cancer formation in mice that are genetically identical at birth. Moreover, this information can be used in the future to perform personalized imageguided therapy. The small size of the instrument allows for its use as an adjunct to standard medical endoscopes. To the best of our knowledge, this is the first report of an ultrathin, flexible, scanning endoscope that can concurrently image more than one specific molecular probe in different spectral regimes in vivo.
This study is also the first to show dual peptide binding of colonic dysplasia in vivo. Previously, we were able to report the peptide QPIHPNNM as a colon dysplasia specific peptide found from in vivo panning with a T7 18-mer combinatorial phage library. The QPIHPNNM peptide was used to demonstrate the feasibility in vivo fluorescence imaging using wide-field non-scanning endoscopy or microendoscopy. 5, 19 While the non-scanning endoscope used offers a wide-field view, sub-cellular resolution was not achievable. On the other hand, the micro-endoscope offers sub-cellular resolution during imaging, but is limited by its field of view (~600 micron diameter). The SFE offers a wide-field view with higher image quality and 6x resolution than comparable flexible fiberscopes than the nonscanning endoscope, making it an attractive modality to test the binding activity of multiple-targets in vivo. To identify additional peptides that preferentially bind to colonic dysplasia in the mouse, the M13 7-mer phage display library was used to isolate candidate clones. While the T7 bacteriophage system has advantages over the M13 bacteriophage system, such as less amplification bias, the 18-mer peptides were more difficult to consistently synthesize and conjugate to a variety of fluorophores. As a result, we chose to pursue the 7-mer M13 system to isolate peptide candidates to evaluate with the SFE system. After implementing a heart perfusion step during panning, repeated phages were not isolated after the third round of panning. Thus, multiple methods of validation, including phage counting, flow cytometry and non-scanning fluorescence endoscopy, were used to identify KCCFPAQ, AKPGYLS and LTTHYKL as promising candidates for in vivo detection with the SFE.
We chose the organic dyes DEAC, TAMRA, and CF633 to label the 3 target peptides because their absorption peaks were close to the excitation wavelengths of the 3 laser sources. However, there are other dyes available at each wavelength, and we considered other important parameters, including fluorophore solubility, synthesis feasibility, fluorescence at neutral pH, biodistribution, clearance, and potential toxicity for future clinical use, before making our final decision. Moreover, the covalent conjugation of these dyes to the peptide must not affect the binding activity of the targeting moiety. While no clinical data has been reported for use of these dyes, there is reason to believe that each of these fluorophores will be safe for human use, in particular with topical application. Coumarin derivatives have been shown to be safe in a number of pre-clinical studies. 20 TAMRA is structurally similar to fluorescein, an imaging agent that is FDA-approved for human use. In addition, CF633 belongs to the carbocyanine family along with indocyanine green, another FDA approved dye.
The reported T/B ratios for AKP-TM and KCC-DC with the SFE are consistent with the T/B ratios found for AKP-FITC and KCC-FITC obtained with the non-scanning endoscope, validating AKPGYLS and KCCFPAQ as preferential binding peptides for colonic dysplasia. The resolution of the SFE images is superior to the nonscanning endoscope, thus is an attractive methodology for detecting tumor margins in vivo as a guide for endoscopic mucosal resection. The ultrathin dimensions and flexibility of the SFE allows for seamless integration with conventional medical endoscopes via a standard instrument channel. Moreover, the lasers, detectors and data acquisition system are conveniently contained within a portable cart that can be easily transported around a procedure room. This integrated methodology has the potential to advance our ability to perform early detection of cancer and image guided therapy in the clinic by simultaneously visualizing multiple molecular targets to better understand the heterogeneous nature of transformed tissues, and the compact size of this instrument allows for application to not only the digestive tract but to other hollow organs in general.
These results demonstrate the in vivo use of a multi-spectral scanning fiber endoscope to collect wide-field fluorescence images in real time from three peptides that are highly specific for dysplasia in a murine model of colorectal cancer. This integrated methodology has the potential to advance early cancer detection and imageguided therapy in human patients by simultaneously visualizing multiple gene targets that are over-expressed in neoplasia. The small size of this instrument allows for endoscope compatibility and for generalizing the future use of this imaging strategy to other hollow organs. Routine histology (H&E) of G) adenoma shows features similar to that seen in sporadic human adenomas, including enlarged nuclei, hyperchromaticity, and distorted crypt architecture, and H) normal appearing adjacent colonic mucosa, scale bar 100 µm. 
